JC
Joseph Catanzaro Piper Sandler Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
ImmunityBio
IBRX
$2.27B
| $2.40 | $5 |
108%
upside
| Overweight | 3 months ago |
|
2
CytomX Therapeutics
CTMX
$376M
| $2.28 | $5 |
119%
upside
| Overweight | 3 months ago |
|
3
Iovance Biotherapeutics
IOVA
$901M
| $2.49 | $6 |
141%
upside
| Neutral | 6 months ago |
|
4
Schrodinger
SDGR
$1.41B
| $19.13 | $45 |
135%
upside
| Overweight | 6 months ago |
|
5
Merus
MRUS
$5.1B
| $67.47 | $84 |
25%
upside
| Overweight | 6 months ago |
|
6
Gilead Sciences
GILD
$143B
| $115.05 | $110 |
4%
downside
| Overweight | 6 months ago |
|
7
Exelixis
EXEL
$10.2B
| $37.88 | $38 |
0%
upside
| Overweight | 6 months ago |
|
8
Keros Therapeutics
KROS
$633M
| $15.59 | $15 |
4%
downside
| Overweight | 7 months ago |
|
9
Halozyme
HALO
$8.76B
| $74.93 | $53 |
29%
downside
| Neutral | 7 months ago |
|
10
Revolution Medicines
RVMD
$7.57B
| $40.50 | $70 |
73%
upside
| Overweight | 10 months ago |
|
11
Immatics
IMTX
$761M
| $6.26 | $19 |
204%
upside
| Overweight | 11 months ago |
|
|
LENZ
12
LENZ Therapeutics
LENZ
$1.2B
| $41.98 | $36 |
14%
downside
| Overweight | 1 year ago |
|
13
Day One Biopharmaceuticals
DAWN
$773M
| $7.55 | $40 |
430%
upside
| Overweight | 1 year ago |
|
14
Ocular Therapeutix
OCUL
$2.37B
| $13.60 | $15 |
10%
upside
| Overweight | 1 year ago |
|
15
Nurix Therapeutics
NRIX
$758M
| $9.91 | $35 |
253%
upside
| Overweight | 1 year ago |
|
|
IMAB
16
I-MAB
IMAB
$358M
| $4.38 | $10 |
128%
upside
| Overweight | 1 year ago |
|
17
Tango Therapeutics
TNGX
$772M
| $6.94 | $18 |
159%
upside
| Overweight | 1 year ago |
|
18
Catalyst Pharmaceutical
CPRX
$2.48B
| $20.29 | $20 |
1%
downside
| Overweight | 2 years ago |
|
19
FIGS
FIGS
$1.12B
| $6.89 | $35 |
408%
upside
| Overweight | 4 years ago |
|